This inventor holds 1 USPTO granted patent. Top assignee: Novartis Vaccines & Diagnostics, Gmbh. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Innovations of Kris G Mendenhull
Introduction
Kris G Mendenhull is an accomplished inventor based in Concord, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of new compounds. Her work focuses on indole and benzimidazole derivatives, which have important applications in medicine.
Latest Patents
Kris G Mendenhull holds 1 patent for her invention titled "Indole and benzimidazole derivatives." This patent relates to new indole and benzimidazole compounds, along with their pharmaceutically acceptable salts, esters, or prodrugs. The invention also includes compositions of these new compounds combined with pharmaceutically acceptable carriers, highlighting their potential uses in therapeutic applications.
Career Highlights
Kris is currently employed at Novartis Vaccines & Diagnostics GmbH, where she continues to innovate and contribute to the field of pharmaceuticals. Her expertise in developing new compounds has positioned her as a valuable asset in her organization.
Collaborations
Kris has collaborated with notable colleagues, including Weibo Wang and Rustum S Boyce. These partnerships have enhanced her research and development efforts, leading to advancements in her field.
Conclusion
Kris G Mendenhull's work exemplifies the impact of innovation in pharmaceuticals, particularly through her patent on indole and benzimidazole derivatives. Her contributions continue to shape the future of medical research and development.